SUN ZHIPENG

Prof. SUN ZHIPENG

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
SZSUN ZHIPENG
SUN ZHIPENG
NZNengwei Zhang
Nengwei Zhang
In the clinical practice of neoadjuvant chemotherapy, response markers are very important. We aimed o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4(carbohydrate antigen 72–4), and CA125(carbohydrate antigen 125) can be used to evaluate the response to neoadjuvant chemotherapy, and to evaluate the diagnosis and prognosis value of four tumor markers in the patients of gastric cancer.

1 January 2016 in BioScience Trends
Verified
Journal Article
Closed access
PDF file
SZSUN ZHIPENG
SUN ZHIPENG
YZYubing Zhu
Yubing Zhu
JXJufeng Xia
Jufeng Xia
TSTatsuo Sawakami
Tatsuo Sawakami
NKNorihiro Kokudo
Norihiro Kokudo
NZNengwei Zhang
Nengwei Zhang
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 January 2015 in BioScience Trends
Verified
Journal Article
Closed access
PDF file
SZSUN ZHIPENG
SUN ZHIPENG
WTWei Tang
Wei Tang
YSYoshihiro Sakamoto
Yoshihiro Sakamoto
KHKiyoshi Hasegawa
Kiyoshi Hasegawa
NKNorihiro Kokudo
Norihiro Kokudo
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

2 November 2020 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
XZXuejing Zheng
Xuejing Zheng
QSQing Sang
Qing Sang
LWLiang Wang
Liang Wang
GCGuanyang Chen
Guanyang Chen
YGYiFan Guo
YiFan Guo
SZSUN ZHIPENG
SUN ZHIPENG

25 November 2015 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
SZSUN ZHIPENG
SUN ZHIPENG
YZYubing Zhu
Yubing Zhu
NZNengwei Zhang
Nengwei Zhang
Although laparoscopic spleen-preserving distal pancreatectomy surgery is more and more popular, the reports about the en bloc technique used for pancreatic cancer were still rare. The aim of our study was to illustrate the detail of the spleen-preserving en bloc technique as well as the short-term and long-term outcomes. The detail of the en bloc technique with pictures was described. The prognosis of the successive 23 cases that underwent the laparoscopic distal pancreatectomy (LDP) surgery was evaluated. There were 17 cases that underwent spleen-preserving LDP while six cases underwent spleen-resecting LDP. The average surgery time was 203 ± 54 min, and the average blood loss volume was 208 ± 264 ml; one case transferred to open surgery because of severe adhesion. The complication rate was 47 % (n = 8) shortly after surgery. Pancreatic fistula rate was 41 % (n = 7). No lethal case occurred. The average diameter of the tumor was 32 ± 12 mm. The average number of the lymph nodes obtained was 19.8 ± 9.3. All the cutting edges were negative. Survival rates of the patient after 1, 3, and 5 years are 64.7, 52.9, and 41.2 %, respectively. These records showed no statistical significance compared with spleen-resecting LDP and open distal pancreatectomy (ODP) surgeries. The en bloc spleen-preserving LDP can be performed by experienced surgeons. This surgery has good short-term and long-term outcomes.

1 August 2009 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
PZPing Zhang
Ping Zhang
XDXiaohong Du
Xiaohong Du
SZSUN ZHIPENG
SUN ZHIPENG
LXLijun Xu
Lijun Xu